Archived
Nausées-vomissements induits par les traitements anticancéreux (NVITAC) en onco-hématologie pédiatrique : recommandations 2022 du Comité soins de support de la SFCE. Antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: 2022: Guidelines from the supportive care committee of the French Society of Childhood Cancer (SFCE)
Overview
On the basis of Anglo-Saxon recommendations and a literature summary, the working group of the Support Care Committee of the French Society for Childhood and Adolescent Cancer (SFCE ) offers guidance for the management of chemotherapy-induced nausea and vomiting in children.
